- Catalogs
- Michelson Diagnostics
- VivoSight OCT Patient Brochure (English)
VivoSight OCT Patient Brochure (English)
VivoSight OCT Patient Brochure (English)
This leaflet introduces VivoSight, a technology designed to assist dermatologists in diagnosing and treating Non Melanoma Skin Cancer (NMSC) effectively.
About Non Melanoma Skin Cancer
NMSC is not life-threatening but requires attention. It includes three main types:
- Actinic Keratoses (AK): Scaly growths from sun damage, potentially leading to squamous cell carcinoma if untreated.
- Squamous Cell Carcinoma (SCC): Abnormal growths on the skin surface, appearing as scaly patches or open sores.
- Basal Cell Carcinoma (BCC): Growths in the epidermis, potentially disfiguring if untreated, appearing as open sores or shiny bumps.
Diagnosis of Non Melanoma Skin Cancer
Traditionally, dermatologists use dermatoscopes and biopsies for diagnosis. VivoSight offers a non-invasive alternative, providing immediate insights without a biopsy.
What is VivoSight?
VivoSight is an imaging technology using infrared light to view beneath the skin's surface, aiding in the assessment of suspected NMSC lesions.
Benefits of VivoSight Examination
- Immediate diagnosis without biopsy.
- Informed treatment decisions, potentially avoiding surgery.
- Monitoring treatment progress and success.
How VivoSight Works
Similar to ultrasound, VivoSight uses infrared light to create images. It is non-invasive and painless.
Safety and Comfort
VivoSight is safe, originally developed for eye use, and is completely painless.
Impact on Treatment
- Assists in determining non-invasive treatment options.
- Identifies lesion extent, reducing repeat surgeries and preserving healthy skin.
Results Timeline
The scan is quick, requiring no preparation, with immediate image assessment by the dermatologist.
For more information, visit www.vivosight.com.
Catalog excerpts
A gentler approach to skin cancer diagnosis
Open the catalog to page 1
This leaflet will explain how a VivoSight examination can help your dermatologist to effectively assess and treat your Non Melanoma Skin Cancer. How is Non Melanoma Skin Cancer diagnosed? Your dermatologist will normally examine your skin using a dermatoscope (magnifying glass) and if necessary take a biopsy to make a diagnosis. A biopsy involves removing a piece of skin which is sent away to a Pathology Laboratory for analysis. Newer techniques, such as the VivoSight scanner, are increasingly used by dermatologists to assist their assessment of Non Melanoma Skin Cancer. About Non Melanoma Skin...
Open the catalog to page 2
Is it safe? VivoSight is completely harmless. The imaging technique was originally invented for use in the eye, where its use is now routine. Is it painful? VivoSight is completely non-invasive and painless. How will this affect my treatment? • It can help your dermatologist decide whether you can be treated non-invasively, for example with the application of a topical cream. The images can also show if your NMSC is more advanced and may need to be surgically removed. • If surgery is required it can help identify the extent of the lesion and reduce the risk of repeat procedures being required.1...
Open the catalog to page 3All Michelson Diagnostics catalogs and technical brochures
VivoSight Research Brochure5 Pages
